PMH21 COST-EFFECTIVENESS OF OLANZAPINE LONG-ACTING INJECTION IN THE TREATMENT OF NON-ADHERENCE PATIENTS WITH SCHIZOPHRENIA IN THE UNITED STATES
May 1, 2009, 00:00
10.1016/S1098-3015(10)73942-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)73942-5/fulltext
Title :
PMH21 COST-EFFECTIVENESS OF OLANZAPINE LONG-ACTING INJECTION IN THE TREATMENT OF NON-ADHERENCE PATIENTS WITH SCHIZOPHRENIA IN THE UNITED STATES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73942-5&doi=10.1016/S1098-3015(10)73942-5
First page :
Section Title :
Open access? :
No
Section Order :
424